Cortechs.ai | Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

Traumatic Brain Injury (TBI) is a significant concern in contact sports, affecting athletes at all levels, from youth leagues to professional sports. TBIs, particularly concussions, can lead to both short- and long-term neurological impairments, impacting cognitive function, emotional regulation, and overall brain health. While many concussions resolve over time, repeated injuries or undiagnosed TBIs can increase the risk of chronic traumatic encephalopathy (CTE) and other neurodegenerative conditions.

Detecting and monitoring TBI as early as possible is critical for optimizing recovery and preventing further damage. Volumetric brain changes can be seen hours after injury, usually associated with edema, and weeks and months after injury when atrophy starts to occur. Traditional assessment methods, such as symptom checklists and cognitive testing, are often subjective and can miss underlying brain changes after the initial injury. Advanced neuroimaging solutions offer a more objective approach by providing detailed insights into brain structure and function, allowing clinicians to track injury progression and recovery.

NeuroQuant is an FDA-cleared automated software that analyzes MRI scans to quantify brain volume and detect changes over time. By providing objective, volumetric data, NeuroQuant enhances TBI assessment, enabling clinicians to measure subtle changes that might not be visible in traditional imaging. This technology is particularly beneficial for athletes who experience repetitive head trauma, offering a way to track brain health throughout their careers.

 

How NeuroQuant Works in TBI Assessment
The NeuroQuant Total Brain Atrophy (TBA) Report leverages volumetric MRI analysis to measure specific brain regions commonly affected by TBI, such as the hippocampus, thalamus, brain stem, where neurodegeneration has been linked to memory and coordination deficits. Additionally, NeuroQuant compares an athlete’s brain volume measurements to a normative database, providing a clear, quantitative picture of how the brain is changing post-injury.

Cortechs.ai | Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

 

The Power of Longitudinal Analysis for Athletes
One of the key advantages of NeuroQuant is its ability to track brain volume changes over time. Longitudinal monitoring helps clinicians evaluate an athlete’s recovery trajectory and determine whether they are at risk for prolonged impairment. This is crucial for return-to-play decisions, ensuring that athletes do not resume activities before their brains have fully healed.
Additionally, ongoing monitoring can:

  • Identify trends that may indicate delayed recovery or increased susceptibility to further injury
  • Guide personalized rehabilitation strategies based on objective neuroimaging data
  • Provide athletes and their families with critical insights into their brain health, helping them make informed decisions about their careers

Research Supporting Volumetric Quantification in TBI Recovery
Scientific research has consistently demonstrated that volumetric brain changes play a critical role in understanding TBI recovery. Studies using automated MRI quantification techniques have shown that brain volume loss can persist for months to years following injury, even in cases where symptoms appear to have resolved. This ongoing atrophy is particularly relevant for athletes exposed to repeated head impacts, as cumulative injuries may accelerate neurodegeneration.

Research has also highlighted that regions such as the hippocampus, thalamus, and corpus callosum exhibit measurable atrophy in athletes with a history of concussions. Advanced neuroimaging studies have linked these volumetric reductions to cognitive deficits, reduced reaction times, and impaired decision-making—factors that are critical for athletic performance and long-term brain health. By integrating volumetric assessments into standard TBI management, clinicians can detect early structural changes that may not be visible on conventional scans. This approach provides a more precise measure of recovery and helps guide safer return-to-play decisions, ensuring that athletes do not return to high-impact sports while their brains are still vulnerable.

Conclusion: Advancing Athlete Brain Health with NeuroQuant
As the understanding of TBI evolves, so must the methods used to diagnose and monitor brain injuries. NeuroQuant offers a game-changing approach to TBI management by providing precise, quantitative insights into brain volume changes. By integrating volumetric analysis into athlete care, clinicians can make more informed decisions, improve recovery outcomes, and help prevent long-term neurological damage. For athletes, teams, and healthcare providers, embracing cutting-edge neuroimaging solutions like NeuroQuant is a crucial step in ensuring brain health remains a priority both on and off the field.

More Resources

01/22/2026

Reflecting on a Transformative Year at Cortechs.ai

As we enter 2026, we want to take a moment to reflect on what has been a truly impactful year at Cortechs.ai.

12/18/2025

Reimbursement Essentials for Quantitative Imaging: Key Takeaways From Our Expert Webinar

Our reimbursement webinar walked through best practices for billing, coding, and securing payment for NeuroQuant and OnQ Prostate, helping inform providers.

12/15/2025

OnQ Prostate for Radiation Oncology

OnQ Prostate is at the forefront of advanced imaging to empower the delivery of true precision therapies.

12/10/2025

Reflections on RSNA 2025 and What We Learned at the Cortechs.ai Booth 

If there was one overall takeaway from RSNA 2025, it’s that clinicians are ready for tools that reduce manual work and make reporting more consistent.

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

12/09/2025

SNO 2025 Recap: Collaboration Driving Innovation in Neuro-Oncology

The 2025 Society for Neuro-Oncology meeting was more than a conference, it was a hub of collaboration and conversation among industry leaders and physicians.
Scroll to Top